Menu Search
Equities

Sanai Health Industry Group Co Ltd

WUP0:FRA

Sanai Health Industry Group Co Ltd

Actions
  • Price (EUR)0.0176
  • Today's Change0.000 / -2.22%
  • Shares traded--
  • 1 Year change-84.36%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Sanai Health Industry Group Co Ltd's revenues fell -30.60% from 175.92m to 122.10m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 29.22m to 18.63m, a -36.23% decrease.
Gross margin17.99%
Net profit margin7.71%
Operating margin16.20%
Return on assets1.74%
Return on equity4.47%
Return on investment2.21%
More ▼

Cash flow in CNYView more

In 2023, Sanai Health Industry Group Co Ltd increased its cash reserves by 1,422.39%, or 310.64m. The company earned 320.69m from its operations for a Cash Flow Margin of 262.65%. In addition the company generated 363.00k cash from investing, though they paid out 9.60m more in financing than they received.
Cash flow per share0.0726
Price/Cash flow per share3.55
Book value per share2.35
Tangible book value per share2.33
More ▼

Balance sheet in CNYView more

Sanai Health Industry Group Co Ltd appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 332.47m. In fact, 8.88% of the value of Sanai Health Industry Group Co Ltd shares can be attributed to this cash.
Current ratio4.21
Quick ratio4.10
Total debt/total equity0.1318
Total debt/total capital0.1077
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.